Investigating the causes of blood platelet defects and related health issues.
Developmental causes of syndromic Thrombocytopenia and co-morbidities
This study is looking into how certain genetic factors during early development can lead to low platelet counts and related health issues, with the hope that the findings will help improve diagnosis and treatment for patients with these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10850978 on NIH RePORTER |
What this research studies
This research focuses on understanding the developmental origins of syndromic thrombocytopenia, a condition characterized by low blood platelet counts and associated health problems. By examining the embryonic development of blood precursor cells and their connection to other organ systems, the study aims to uncover the genetic and biological mechanisms behind these disorders. The research utilizes advanced techniques such as CRISPR to manipulate genes and observe their effects on development in model organisms. Patients may benefit from insights that could lead to improved diagnosis and treatment options for related conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with syndromic thrombocytopenia or related congenital hematopoietic disorders.
Not a fit: Patients with non-syndromic thrombocytopenia or those without any hematological disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of syndromic thrombocytopenia and its associated health issues.
How similar studies have performed: Previous research has shown promise in understanding genetic contributions to hematopoietic disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Burger, Alexa — University of Colorado Denver
- Study coordinator: Burger, Alexa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.